semaglutide rapid dissolve tablets Wegovy for Weight Management Details of failed studies cast

Strong indicators that you are ready for the next dose step include: GI side effects have fully resolved at the current dose Appetite suppression has stabilized (not increasing or decreasing week to week) Weight loss has slowed or plateaued at the current dose Energy levels are stable and consistent Sleep quality has returned to baseline Indicators that you should hold at the current dose for another cycle include: Persistent nausea beyond the first week at the current dose Digestive issues that have not resolved Weight loss is still progressing well (no need to increase if current dose is working) Energy levels are still adjusting Any concerning symptoms that need medical evaluation The tracking data also helps identify your optimal maintenance dose

The percentages of subjects who were hospitalized for HF were 4.0 and 4.2% in the lixisenatide and placebo group, respectively (HR 0.96

10.1002/jcp.29835 32 WeiR.CuiX.FengJ.GuL.LangS.WeiT.et al (2020)

The results also highlighted potential side effects: about a third of participants reported nausea or diarrhea, while about a quarter reported constipation

Your healthcare provider will determine the appropriate dosage for your treatment plan

[11] [12] Regular follow-up appointments provide opportunities to discuss any adverse effects, including sleep changes, and to optimise treatment plans